These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 702178)

  • 1. Inhibition of dopamine-sensitive adenylate cyclase in rat striatum by neuroleptic drugs administered in vivo.
    Nakahara T; Uchimura H; Saito M; Hirano M; Kim JS; Ito M
    J Neurochem; 1978 Nov; 31(5):1335-7. PubMed ID: 702178
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors affecting solubilized dopamine-sensitive adenylate cyclase.
    Marshall AM; Ramwani J; Mishra RK
    Biochem Pharmacol; 1983 Apr; 32(7):1237-41. PubMed ID: 6847713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of the dopamine sensitive adenylate cyclase for antipsychotic antagonists.
    Roufogalis BD; Thornton M; Wade DN
    Life Sci; 1976 Sep; 19(6):927-34. PubMed ID: 966971
    [No Abstract]   [Full Text] [Related]  

  • 4. Striatal adenylate cyclase activity following reserpine and chronic chlorpromazine administration in rats.
    Rotrosen J; Friedman E; Gershon S
    Life Sci; 1975 Aug; 17(4):563-8. PubMed ID: 171534
    [No Abstract]   [Full Text] [Related]  

  • 5. Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases.
    Bockaert J; Tassin JP; Thierry AM; Glowinski J; Premont J
    Brain Res; 1977 Feb; 122(1):71-86. PubMed ID: 837225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different dopamine stimulation of adenylate cyclase in striatum and mesolimbic area of rats treated with chronic chlorpromazine.
    Kaneno S; Watanabe S; Toru M; Shimazono Y
    Brain Res; 1978 Aug; 152(2):396-400. PubMed ID: 679034
    [No Abstract]   [Full Text] [Related]  

  • 7. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haloperidol increases and apomorphine decreases striatal dopamine metabolism after destruction of striatal dopamine-sensitive adenylate cyclase by kainic acid.
    Di Chiara G; Porceddu ML; Spano PF; Gessa GL
    Brain Res; 1977 Jul; 130(2):374-82. PubMed ID: 884534
    [No Abstract]   [Full Text] [Related]  

  • 9. Stimulation of a dopamine-sensitive adenylate cyclase in homogenates of rat striatum by a metabolite of piribedil (ET 495).
    Miller RJ; Iversen LL
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(2):213-6. PubMed ID: 4369214
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurohumoral regulation of adenylate cyclase activity in rat striatum.
    Walker JB; Walker JP
    Brain Res; 1973 May; 54():386-90. PubMed ID: 4145382
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased sensitivity of adenylate cyclase activity in the striatum of the rat to calmodulin and GppNHp after chronic treatment with haloperidol.
    Treisman GJ; Muirhead N; Gnegy ME
    Neuropharmacology; 1986 Jun; 25(6):587-95. PubMed ID: 3092124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular localization of dopamine-sensitive adenylate cyclase in rat brain striatum.
    Laduron P; Verwimp M; Janssen PF; Leysen J
    Life Sci; 1976 Feb; 18(4):433-9. PubMed ID: 130527
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of some derivatives of 2-aminotetralin on dopamine-sensitive adenylate cyclase and on the binding of (3H)haloperidol to neuroleptic receptors in the rat striatum.
    Cannon JG; Costall B; Laduron PM; Leysen JE; Naylor RJ
    Biochem Pharmacol; 1978 May; 27(10):1417-20. PubMed ID: 567987
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative study of the dopamine-sensitive adenylate cyclase in the striatum and hypothalamus of rat brain.
    Roufogalis BD; Thornton M; Wade DN
    J Pharm Pharmacol; 1979 Jan; 31(1):33-8. PubMed ID: 32363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic drugs and dopamine-stimulated adenylate cyclase prepared from corpus striatum of rat brain.
    Karobath M; Leitich H
    Proc Natl Acad Sci U S A; 1974 Jul; 71(7):2915-8. PubMed ID: 4527668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a connection between high affinity 3H-spiperone binding sites and DA-sensitive adenylate cyclase in corpus striatum?
    Marchais D; Bockaert J
    Biochem Pharmacol; 1980 May; 29(10):1331-6. PubMed ID: 7053066
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the inhibitory effects of neuroleptic drugs on adenylate cyclase in rat tissues stimulated by dopamine, noradrenaline and glucagon.
    Miller RJ
    Biochem Pharmacol; 1976 Mar; 25(5):537-41. PubMed ID: 942490
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of morphine sulfate on adenylate cyclase and phosphodiesterase activities in rat corpus striatum.
    Puri SK; Cochin J; Volicer L
    Life Sci; 1975 Mar; 16(5):759-67. PubMed ID: 164598
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of penfluridol of dopamine-sensitive adenylate cyclase in corpus striatum and substantia nigra of rats.
    Seeber U; Kuschinsky K
    Experientia; 1976 Dec; 32(12):1558-9. PubMed ID: 191279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of dopamine sensitive adenylate cyclase from rat brain striatal homogenates by ascorbic acid.
    Thomas TN; Zemp JW
    J Neurochem; 1977 Mar; 28(3):663-5. PubMed ID: 853306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.